LPS acts as a potent inflammatory stimulus, triggering the production of pro-inflammatory mediators such as cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2), which are closely linked to IBD progression (Cianciulli et al., 2012). Here, PTGS2 is linked to inflammatory bowel disease.